IPC
KYNB

Independent Portfolio Consultants’s Kyntra Bio KYNB Stock Holding History

Independent Portfolio Consultants’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-67
Closed -$37K – 774
2015
Q3 		$37K Buy
+67
New +$40.6K 0.01% 623

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Independent Portfolio Consultants's KYNB Position: Q4 2015 in Review

Independent Portfolio Consultants sold out of Kyntra Bio (KYNB) in Q4 2015, closing a stake of 67 shares — an estimated $37K sold.

Independent Portfolio Consultants first reported a position in KYNB in Q3 2015 and held it in 1 quarter. The position peaked at $37K in Q3 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q4 2015.

  • Independent Portfolio Consultants reported no remaining Kyntra Bio position as of Q4 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 67 Kyntra Bio shares in Q4 2015, an estimated $37K.
  • Independent Portfolio Consultants first reported a position in Kyntra Bio in Q3 2015 and held it in 1 quarter.
  • Independent Portfolio Consultants's Kyntra Bio position peaked at $37K in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2015.

Based on Independent Portfolio Consultants's 13F filing for Q4 2015, filed 12 Jan 2016.